Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8656627 | Atherosclerosis | 2018 | 7 Pages |
Abstract
These findings suggest that, compared with non-FH subjects, atherosclerotic lesions in FH heterozygotes may be hyper-responsive to LDL-lowering therapy, whereas treatment of homozygous FH remains a major challenge.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gilbert R. Thompson,